- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Fund Finance
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- Innovation Protection
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Innovation Protection
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy Transition
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- Artificial Intelligence (AI) and Machine Learning
- Buy American
- Crisis Management
- Doing Business in Latin America
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Institutional Culture and Sensitive Investigations
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
Ulf H. Grundmann
News 26 results
Cases & Deals
Recognition
März 26, 2025
Legal 500 EMEA 2025 Ranks King & Spalding among the Top Firms in Europe, the Middle East and Africa
Recognition
Februar 13, 2025
Legal 500 Deutschland 2025 Ranks King & Spalding Among Germany’s Leading Law Firms
Recognition
Mai 17, 2024
LMG Life Sciences EMEA Names Ulf Grundmann its Parallel Import Lawyer of the Year
Events 36 results
Webinar
Januar 28, 2025
Food for Thought: What the Food & Beverage Industry Can Expect in 2025
Speaking Engagement
Dezember 13, 2024
Ulf Grundmann to Speak at Frankfurt School of Finance and Management’s International Healthcare Management MBA program
Webinar
November 28, 2024
Virtual Talk im Turm: Health Claims in Advertising Botanicals (ECJ Case C-386/23)
Webinar
November 27, 2024
Virtual Talk im Turm: EU Regulation on “Green Claims” – How to Ensure Compliance
Insights 15 results
Client Alert
Juli 22, 2024
EU Artificial Intelligence Regulation Published - What You Need to Know
Feature
Dezember 8, 2023
General Counsel’s Decision Tree for Internal Investigations for the Food and Beverage Industry
Client Alert
Juni 22, 2023
EU Aims for Ban of PFAS. Now is the Time to Act.